Bio-Techne Corp. stock underperforms Friday when compared to competitors
Shares of Bio-Techne Corp. TECH shed 2.04% to $58.73 Friday, on what proved to be an all-around poor trading session for the ...
Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch
Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research ...
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet ...
Bio-Techne Corp. stock outperforms competitors despite losses on the day
Shares of Bio-Techne Corp. TECH slipped 1.78% to $59.98 Tuesday, on what proved to be an all-around favorable trading session ...
Bio-Techne highlights advances in detection of biomarkers using RNAscope
Corporation announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...
Proficio Capital Partners LLC Grows Stock Position in Bio-Techne Co. (NASDAQ:TECH)
Proficio Capital Partners LLC increased its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 13.6% in the 4th quarter, according to its most recent disclosure with the SEC. The ...
Morningstar5d
Bio-Techne Corp TECH
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.